MNK INVESTOR NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation – MNK

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Mallinckrodt plc (NYSE American: MNK) resulting from allegations that Mallinckrodt may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Mallinckrodt […]

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Mallinckrodt plc (NYSE American: MNK) resulting from allegations that Mallinckrodt may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Mallinckrodt securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=13407 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On March 17, 2023, The Buxton Helmsley Group, Inc., a “New York City-based investment advisor to clients with financial interests in Mallinckrodt Plc.” issued two open letters and press releases, later corrected. In a corrected press release, Buxton Helmsley Group alleged that it is “delivering the results of an extensive investigation into financial misconduct at the Company involving an evidenced scheme of concealing asset value depreciation/impairment expenses, in violation of GAAP ASC 350, 360 and Regulation S-X, taking place both before and after the Company’s Chapter 11 Reorganization.”

The Buxton Helmsley Group also alleged that it is “demanding the restatement of the historical financial statements of the Company, and demanding write-downs of post-reorganization asset values based on the Company’s prior-professed standards of determining the fair value of asset’s securing the Company’s capital structure.”

On this news, the price of Mallinckrodt’s stock price fell 5% to close at $7.78 per share on March 20, 2023.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8808223

Previous Article

Putting people at the heart of hybrid work: Zoom to acquire Workvivo to bolster the employee experience offering

Next Article

LPLA INVESTOR NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages LPL Financial Holdings Inc. Investors to Inquire About Class Action Investigation – LPLA

Related Posts

‫500 شركة مختارة بعناية من الشركات الصغيرة والمتناهية الصغر والمتوسطة تنطلق نحو العالمية في معرض UMKM EXPO(RT) BRIlianpreneur 2021 المقرر عقد افتراضيًا عبر الإنترنت

العاصمة جاكرتا، إندونيسيا, 19 نوفمبر 2021 – ينظم بنك راكيات إندونيسيا (BRI) معرض UMKM EXPO(RT) BRIlianpreneur 2021 في الفترة من 9 إلى 16 ديسمبر 2021، بمشاركة 500 شركة مختارة بعناية من الشركات الصغيرة ومتناهية الصغر والمتوسطة لعرض منتجاتهم عبر الواقع الافتراضية)، وذلك عقب المعرض الناجح المنعقد لدورتين على التوالي عبر منصة /PRNewswire/. صرح السيد/ سونارسو، رئيس […]

GMT Token builds data centers in Norway

SINGAPORE, Oct. 7, 2022 /PRNewswire/ — GMT Token’s team is expanding geographically and has launched a new data center in Norway. The new 20-MW data center is located near Oslo. One of GMT’s main goals is possessing the newest and most energy efficient equipment, so 2,950 new Antminer S19 miners have been installed. The number […]

MA’ADEN and GlassPoint sign a Memorandum of Understanding (“MOU”) to develop the world’s largest solar process steam plant

Saudi Arabia’s leading mining company signs an MOU to facilitate the study to develop the first solar steam project in the kingdom to decarbonize MA’ADEN’s alumina refinery RIYADH, Saudi Arabia, June 2, 2022 /PRNewswire/ — Saudi Arabian Mining Company (MA’ADEN), Saudi Arabia’s national mining champion and one of the fastest-growing mining companies in the world, and […]

Conagen’s New Dihydro Resveratrol Made By Clean Bioconversion Inspires Novel Products and Drives Market Growth

Bedford, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications. Conagen’s dihydro resveratrol is made by bioconversion from p-coumaric acid (pCA), a natural preservative Conagen produced by precision fermentation. The same proprietary bioconversion technology used […]